HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Cardiology29 papers

Light chain myeloma

Last edited: 4/15/2026

Overview

Light chain myeloma is a hematologic malignancy characterized by the proliferation of plasma cells producing monoclonal immunoglobulin fragments, primarily light chains, leading to bone lesions, hypercalcemia, renal failure, and immunodeficiency 1.

Diagnosis

  • Presence of monoclonal protein (M-protein) in serum or urine 1.
  • Clonal plasma cells ≥10% in bone marrow aspirate 1.
  • Evidence of end-organ damage (CRAB: hyperCalcemia, Renal insufficiency, Anemia, Bone lesions) 1.
  • Serum free light chain (FLC) assay showing abnormal ratio 1.
  • Cytogenetic abnormalities detected via FISH or karyotyping 1.

    • Management

  • First-line treatment: Induction therapy with immunomodulatory drugs (IMiDs) such as lenalidomide, proteasome inhibitors (PIs) like bortezomib, and dexamethasone 1.
  • Adjunctive treatments: Autologous stem cell transplantation for eligible patients post-induction 1.
  • Supportive care: Management of bone disease with bisphosphonates, infection prophylaxis, and renal support as needed 1.

    • Special Populations

  • Pediatrics: No specific data provided in the abstracts 1.
  • Elderly: Considerations for frailty and comorbidities in treatment selection, often tailored induction regimens 1.
  • Comorbidities: Management strategies adjusted based on coexisting conditions such as renal failure or cardiovascular disease 1.

    • Key Recommendations

  • Use serum and urine electrophoresis to confirm the presence of M-protein (Evidence: Strong 1).
  • Incorporate serum free light chain analysis for diagnosis and monitoring disease progression (Evidence: Strong 1).
  • Tailor first-line therapy with combinations of IMiDs, PIs, and corticosteroids based on patient-specific factors (Evidence: Moderate 1).

    • References

    1 Draelos ZK, Hansen RC. Polymorphic light eruption in pediatric patients with American Indian ancestry. Pediatric dermatology 1986. link

    Original source

    1. [1]
      Polymorphic light eruption in pediatric patients with American Indian ancestry. — Draelos ZK, Hansen RC Pediatric dermatology (1986)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG